prednisolone acetate has been researched along with sulfacetamide in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
Beane, J; Epstein, JS; Hubbell, R | 1 |
Johansen, S; Prause, JU; Rask-Pedersen, E | 2 |
Auerbach, D; Davies, L; Glonek, T; Greiner, JV; Hearn, SL; Leahy, CD | 1 |
AbdElHamid, G; El-Ragehy, NA; Hegazy, MA; Tawfik, SA | 1 |
1 trial(s) available for prednisolone acetate and sulfacetamide
Article | Year |
---|---|
Prevention of early otorrhea in ventilation tubes.
Topics: Adolescent; Cerebrospinal Fluid Otorrhea; Child; Child, Preschool; Drug Combinations; Female; Humans; Infant; Male; Middle Ear Ventilation; Prednisolone; Prospective Studies; Random Allocation; Sulfacetamide; Surgical Wound Infection | 1992 |
5 other study(ies) available for prednisolone acetate and sulfacetamide
Article | Year |
---|---|
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
A bioavailability comparison in rabbits after a single topical ocular application of prednisolone acetate formulated as a high-viscosity gel and as an aqueous suspension.
Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Aqueous Humor; Biological Availability; Conjunctiva; Cornea; Female; Fusidic Acid; Gels; Glucocorticoids; Ophthalmic Solutions; Prednisolone; Rabbits; Sulfacetamide; Suspensions | 1996 |
An ocular bioavailability comparison in rabbits of prednisolone acetate after repeated topical applications formulated as a high-viscosity gel and as an aqueous suspension.
Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Aqueous Humor; Biological Availability; Conjunctiva; Cornea; Female; Fusidic Acid; Gels; Glucocorticoids; Ophthalmic Solutions; Prednisolone; Rabbits; Sulfacetamide; Suspensions; Viscosity | 1996 |
Effects of eyelid scrubbing on the lid margin.
Topics: Administration, Topical; Animals; Anti-Infective Agents, Local; Blepharitis; Cell Count; Contact Lenses; Drug Combinations; Eyelids; Follow-Up Studies; Prednisolone; Rabbits; Sulfacetamide; Surface-Active Agents | 1999 |
Validated Chromatographic Methods for the Simultaneous Determination of Sulfacetamide Sodium and Prednisolone Acetate in their Ophthalmic Suspension.
Topics: Chromatography, Reverse-Phase; Chromatography, Thin Layer; Linear Models; Ophthalmic Solutions; Prednisolone; Reproducibility of Results; Sensitivity and Specificity; Sulfacetamide; Suspensions | 2017 |